Sponsor Pipeline

PAQ Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
4
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT06797336
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors		 Enrollment increased: 115 -> 240 participants
2026-08-13 NCT06797336
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors		 Trial arms changed: 4 -> 5
2026-08-13 NCT06797336
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors		 Trial sites expanded: 7 -> 15 locations
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07300150 A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors Colorectal Cancer Recruiting
NCT06797336 A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors Solid Tumor Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1)
Get alerts when PAQ Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free